The pharma industry can no longer sit on the sidelines when it comes to digitization.

A 70-year-old technique is helping to cut the development costs of monoclonal antibodies.

We look back on key interviews and opinions from individuals featured on our 2021 Power List.

Primary packaging design needs to consider the needs of all patients.

Let’s not forget the scientists working to improve efficiency and accuracy of the CRISPR – for they are key to unlocking its full potential.

When pushing for more patient-centric drug development, modified release formulations must be considered.

Experts explain how their companies have coped throughout the pandemic.

We reveal The Medicine Maker 2021 Power List!

Why multilayer tablets, multiparticulates, and mini tablets could lead the way in patient-centric drug delivery.

AAM calls for policies in the US that encourage greater use of biosimilars.